| Year |
Citation |
Score |
| 2021 |
McGarry SD, Brehler M, Bukowy JD, Lowman AK, Bobholz SA, Duenweg SR, Banerjee A, Hurrell SL, Malyarenko D, Chenevert TL, Cao Y, Li Y, You D, Fedorov A, Bell LC, ... ... LaViolette PS, et al. Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness. Journal of Magnetic Resonance Imaging : Jmri. PMID 34767682 DOI: 10.1002/jmri.27983 |
0.54 |
|
| 2020 |
McGarry SD, Bukowy JD, Iczkowski KA, Lowman AK, Brehler M, Bobholz S, Nencka A, Barrington A, Jacobsohn K, Unteriner J, Duvnjak P, Griffin M, Hohenwalter M, Keuter T, Huang W, ... ... LaViolette PS, et al. Radio-pathomic mapping model generated using annotations from five pathologists reliably distinguishes high-grade prostate cancer. Journal of Medical Imaging (Bellingham, Wash.). 7: 054501. PMID 32923510 DOI: 10.1117/1.Jmi.7.5.054501 |
0.356 |
|
| 2019 |
Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, ... ... LaViolette PS, et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature. PMID 31748746 DOI: 10.1038/S41586-019-1775-1 |
0.35 |
|
| 2019 |
Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Malyarenko DI, Aryal MP, LaViolette PS, Oborski MJ, O'Sullivan F, Abramson RG, Jafari-Khouzani K, Afzal A, Tudorica A, Moloney B, et al. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II. Tomography (Ann Arbor, Mich.). 5: 99-109. PMID 30854447 DOI: 10.18383/j.tom.2018.00027 |
0.534 |
|
| 2019 |
Lowman A, Barrington A, Cochran E, Connelly J, Mueller W, LaViolette P. TMIC-54. COMPARISON OF CELLULAR FEATURES AT AUTOPSY IN GLIOBLASTOMA PATIENTS WITH STANDARD TREATMENT OF CARE AND TUMOR TREATMENT FIELDS Neuro-Oncology. 21: vi259-vi259. DOI: 10.1093/Neuonc/Noz175.1088 |
0.403 |
|
| 2018 |
Parchur AK, Sharma G, Jagtap JM, Gogineni VR, LaViolette PS, Flister MJ, White SB, Joshi A. Vascular Interventional Radiology Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods. Acs Nano. PMID 29969226 DOI: 10.1021/Acsnano.8B01424 |
0.321 |
|
| 2018 |
McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS. Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29908785 DOI: 10.1016/J.Ijrobp.2018.04.044 |
0.301 |
|
| 2018 |
Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS. Optimized [Formula: see text]-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging. Journal of Medical Imaging (Bellingham, Wash.). 5: 011004. PMID 29098169 DOI: 10.1117/1.Jmi.5.1.011004 |
0.329 |
|
| 2018 |
Barrington A, Hurrell S, Laviolette P. TMIC-10. AUTOPSY STUDY ON THE EFFECTS OF TUMOR TREATMENT FIELDS IN RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS Neuro-Oncology. 20: vi258-vi258. DOI: 10.1093/Neuonc/Noy148.1070 |
0.376 |
|
| 2017 |
Hurrell S, Cochran E, Mueller WM, McGarry S, Schultz CJ, Siker M, Rand S, LaViolette PS, Schmainda KM, Connelly JM. RARE-16. CASE REPORT: DELAYED DEVELOPMENT OF PSEUDOPROGRESSION IN 2 GLIOBLASTOMA PATIENTS TREATED WITH TTFIELDS Neuro-Oncology. 19: vi214-vi214. DOI: 10.1093/Neuonc/Nox168.866 |
0.54 |
|
| 2017 |
Hurrell S, Cochran E, McGarry S, Connelly JM, Schmainda KM, Rand S, Mueller WM, LaViolette P. ACTR-44. AUTOPSY STUDY ON THE EFFECTS OF TUMOR TREATMENT FIELDS IN RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS AND TRIAL DESIGN Neuro-Oncology. 19: vi10-vi10. DOI: 10.1093/Neuonc/Nox168.035 |
0.612 |
|
| 2016 |
McGarry SD, Hurrell SL, Kaczmarowski AL, Cochran EJ, Connelly J, Rand SD, Schmainda KM, LaViolette PS. Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy. Tomography : a Journal For Imaging Research. 2: 223-228. PMID 27774518 DOI: 10.18383/j.tom.2016.00250 |
0.619 |
|
| 2016 |
Nguyen HS, Milbach N, Hurrell SL, Cochran E, Connelly J, Bovi JA, Schultz CJ, Mueller WM, Rand SD, Schmainda KM, LaViolette PS. Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma. Ajnr. American Journal of Neuroradiology. PMID 27492073 DOI: 10.3174/Ajnr.A4898 |
0.654 |
|
| 2016 |
Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Malyarenko DI, Aryal MP, LaViolette PS, Oborski MJ, O'Sullivan F, Abramson RG, Jafari-Khouzani K, Afzal A, Tudorica A, Moloney B, et al. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge. Tomography : a Journal For Imaging Research. 2: 56-66. PMID 27200418 DOI: 10.18383/j.tom.2015.00184 |
0.557 |
|
| 2016 |
Hurrell S, McGarry S, Cochran E, Connelly JM, Rand S, Bovi J, LaViolette PS, Schmainda KM, Kaczmarowski A. NIMG-53. PREDICTIVE CYTOLOGICAL TOPOGRAPHY MAPS REGIONS OF PATHOLOGICALLY CONFIRMED NON-ENHANCING HYPERCELLULAR TUMOR IN GLIOBLASTOMA PATIENTS Neuro-Oncology. 18: vi136-vi136. DOI: 10.1093/Neuonc/Now212.564 |
0.627 |
|
| 2016 |
McGarry S, Hurrell S, Kaczmarowski A, Cochran E, Connelly JM, Bovi J, Rand S, Schmainda KM, LaViolette PS. NIMG-25. RADIOMIC PROFILING MAPS AREAS OF PATHOLOGICALLY CONFIRMED TUMOR AND PREDICTS OVERALL SURVIVAL IN PRE-TREATMENT GLIOBLASTOMA Neuro-Oncology. 18: vi129-vi129. DOI: 10.1093/Neuonc/Now212.537 |
0.622 |
|
| 2015 |
Mickevicius NJ, Carle AB, Bluemel T, Santarriaga S, Schloemer F, Shumate D, Connelly J, Schmainda KM, LaViolette PS. Location of brain tumor intersecting white matter tracts predicts patient prognosis. Journal of Neuro-Oncology. 125: 393-400. PMID 26376654 DOI: 10.1007/S11060-015-1928-5 |
0.651 |
|
| 2015 |
Quirk BJ, Brandal G, Donlon S, Vera JC, Mang TS, Foy AB, Lew SM, Girotti AW, Jogal S, LaViolette PS, Connelly JM, Whelan HT. Photodynamic therapy (PDT) for malignant brain tumors - Where do we stand? Photodiagnosis and Photodynamic Therapy. 12: 530-44. PMID 25960361 DOI: 10.1016/J.Pdpdt.2015.04.009 |
0.368 |
|
| 2015 |
Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS. Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. Journal of Neuro-Oncology. 123: 179-88. PMID 25894597 DOI: 10.1007/S11060-015-1782-5 |
0.349 |
|
| 2015 |
LaViolette P, Milbach N, Connelly J, Rand S, Schmainda K, Cochran E. NIMG-47PATHOLOGICALLY CONFIRMED VIABLE TUMOR SURROUNDS REGIONS OF PROGRESSIVELY EXPANDING DIFFUSION-RESTRICTED NECROSIS FOLLOWING BEVACIZUMAB TREATMENT Neuro-Oncology. 17: v164.3-v164. DOI: 10.1093/Neuonc/Nov225.47 |
0.653 |
|
| 2014 |
Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Roy I, Lemke A, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson DF, Tan W, Fahrenkrug SC, ... ... LaViolette PS, et al. CXM: a new tool for mapping breast cancer risk in the tumor microenvironment. Cancer Research. 74: 6419-29. PMID 25172839 DOI: 10.1158/0008-5472.Can-13-3212 |
0.354 |
|
| 2014 |
LaViolette PS, Mickevicius NJ, Cochran EJ, Rand SD, Connelly J, Bovi JA, Malkin MG, Mueller WM, Schmainda KM. Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma. Neuro-Oncology. 16: 1599-606. PMID 25059209 DOI: 10.1093/Neuonc/Nou142 |
0.631 |
|
| 2014 |
Heroux MS, Chesnik MA, Halligan BD, Al-Gizawiy M, Connelly JM, Mueller WM, Rand SD, Cochran EJ, LaViolette PS, Malkin MG, Schmainda KM, Mirza SP. Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics. Physiological Genomics. 46: 467-81. PMID 24803679 DOI: 10.1152/Physiolgenomics.00034.2014 |
0.579 |
|
| 2014 |
LaViolette PS, Daun MK, Paulson ES, Schmainda KM. Effect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma. Journal of Neuro-Oncology. 116: 543-9. PMID 24293201 DOI: 10.1007/S11060-013-1318-9 |
0.625 |
|
| 2014 |
Pellatt B, Mickevicius N, Cochran E, LaViolette P. NI-64 * 3D-PRINTED MRI-BASED CUSTOM BRAIN MOLDS FOR MINIMIZING TISSUE DISTORTION AND PRECISELY SLICING TISSUE FOR CO-REGISTRATION WITH CLINICALLY ACQUIRED MRI IN GLIOMA PATIENTS Neuro-Oncology. 16: v152-v152. DOI: 10.1093/Neuonc/Nou264.62 |
0.335 |
|
| 2014 |
Mickevicius N, Carle A, Santarriaga-Escamilla S, Bluemel T, Connelly J, Rand S, Mueller W, Schmainda K, LaViolette P. NI-58 * LOCATION OF GLIOBLASTOMA INTERSECTIING WHITE MATTER TRACTS PREDICT PATIENT PROGNOSIS AND RESPONSE TO BEVACIZUMAB PRIOR TO THERAPY Neuro-Oncology. 16: v151-v151. DOI: 10.1093/Neuonc/Nou264.56 |
0.661 |
|
| 2014 |
Al-Gizawiy M, Prah M, Mueller W, LaViolette P, Schmainda K. NI-03 * DSC-MRI MEASURES OF rCBV PREDICT TUMOR CHARACTERISTICS BEYOND STANDARD HISTOPATHOLOGY Neuro-Oncology. 16: v138-v138. DOI: 10.1093/Neuonc/Nou264.3 |
0.647 |
|
| 2013 |
Sabsevitz DS, Bovi JA, Leo PD, Laviolette PS, Rand SD, Mueller WM, Schultz CJ. The role of pre-treatment white matter abnormalities in developing white matter changes following whole brain radiation: a volumetric study. Journal of Neuro-Oncology. 114: 291-7. PMID 23813291 DOI: 10.1007/S11060-013-1181-8 |
0.313 |
|
| 2013 |
Cohen AD, LaViolette PS, Prah M, Connelly J, Malkin MG, Rand SD, Mueller WM, Schmainda KM. Effects of perfusion on diffusion changes in human brain tumors. Journal of Magnetic Resonance Imaging : Jmri. 38: 868-75. PMID 23389889 DOI: 10.1002/Jmri.24042 |
0.615 |
|
| 2013 |
LaViolette PS, Cohen AD, Prah MA, Rand SD, Connelly J, Malkin MG, Mueller WM, Schmainda KM. Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma. Neuro-Oncology. 15: 442-50. PMID 23382287 DOI: 10.1093/Neuonc/Nos323 |
0.616 |
|
| 2012 |
Barr A, Collier W, Piacentine L, Douville K, Durgerian S, LaViolette P, Sabsevitz D, Schmainda K, Chitambar CR, Bloom A. Abstract 2654: A prospective study of the effects of adjuvant chemotherapy (CT) on cognition and brain function in breast cancer patients Cancer Research. 72: 2654-2654. DOI: 10.1158/1538-7445.Am2012-2654 |
0.574 |
|
| 2011 |
Atri A, O'Brien JL, Sreenivasan A, Rastegar S, Salisbury S, DeLuca AN, O'Keefe KM, LaViolette PS, Rentz DM, Locascio JJ, Sperling RA. Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials. Archives of Neurology. 68: 599-606. PMID 21555634 DOI: 10.1001/Archneurol.2011.94 |
0.333 |
|
| 2011 |
Ellingson BM, LaViolette PS, Rand SD, Malkin MG, Connelly JM, Mueller WM, Prost RW, Schmainda KM. Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 65: 1131-43. PMID 21413079 DOI: 10.1002/Mrm.22688 |
0.604 |
|
| 2011 |
LaViolette PS, Rand SD, Ellingson BM, Raghavan M, Lew SM, Schmainda KM, Mueller W. 3D visualization of subdural electrode shift as measured at craniotomy reopening. Epilepsy Research. 94: 102-9. PMID 21334178 DOI: 10.1016/J.Eplepsyres.2011.01.011 |
0.548 |
|
| 2011 |
Putcha D, O'Keefe K, LaViolette P, O'Brien J, Greve D, Rentz DM, Locascio J, Atri A, Sperling R. Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults. Human Brain Mapping. 32: 2027-44. PMID 21259385 DOI: 10.1002/Hbm.21166 |
0.307 |
|
| 2011 |
LaViolette PS, Rand SD, Raghavan M, Ellingson BM, Schmainda KM, Mueller W. Three-dimensional visualization of subdural electrodes for presurgical planning. Neurosurgery. 68: 152-60; discussion 1. PMID 21206319 DOI: 10.1227/Neu.0B013E31820783Ba |
0.537 |
|
| 2011 |
Ellingson BM, Malkin MG, Rand SD, LaViolette PS, Connelly JM, Mueller WM, Schmainda KM. Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas. Journal of Neuro-Oncology. 102: 95-103. PMID 20798977 DOI: 10.1007/S11060-010-0293-7 |
0.681 |
|
| 2010 |
Zyloney CE, Jensen K, Polich G, Loiotile RE, Cheetham A, LaViolette PS, Tu P, Kaptchuk TJ, Gollub RL, Kong J. Imaging the functional connectivity of the Periaqueductal Gray during genuine and sham electroacupuncture treatment. Molecular Pain. 6: 80. PMID 21080967 DOI: 10.1186/1744-8069-6-80 |
0.303 |
|
| 2010 |
Ellingson BM, Malkin MG, Rand SD, Connelly JM, Quinsey C, LaViolette PS, Bedekar DP, Schmainda KM. Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. Journal of Magnetic Resonance Imaging : Jmri. 31: 538-48. PMID 20187195 DOI: 10.1002/Jmri.22068 |
0.586 |
|
| 2008 |
Sperling R, O'Brien J, O'Keefe K, DeLuca A, LaViolette P, Pihlajamaki M, Johnson K, Blacker D, Dickerson B. IC-P2-139: Longitudinal fMRI demonstrates loss of hippocampal function associated with clinical decline in non-demented older subjects Alzheimer's & Dementia. 4: T62-T62. DOI: 10.1016/J.Jalz.2008.05.2593 |
0.303 |
|
| Show low-probability matches. |